
SAGE Therapeutics Misses Q3 EPS by 9c
SAGE Therapeutics (SAGE) reported Q3 EPS of ($2.31), $0.09 worse than the analyst estimate of ($2.22). Revenue for the quarter came in at $1.74 million versus the consensus estimate of $1.68...
SAGE Therapeutics (SAGE) reported Q3 EPS of ($2.31), $0.09 worse than the analyst estimate of ($2.22). Revenue for the quarter came in at $1.74 million versus the consensus estimate of $1.68...
Investing.com - Sage Therapeutic reported on Tuesday third quarter {{erl-940842||earnings that missed analysts' forecasts and revenue that topped expectations. Sage Therapeutic announced...
SAGE Therapeutics (NASDAQ:SAGE) reported Q2 EPS of ($2.13), in-line with the analyst estimate of ($2.13). Revenue for the quarter came in at $1.5 million versus the consensus estimate of...
SAGE Therapeutics (NASDAQ:SAGE) reported Q1 net loss of $122.1 million. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.21 million.
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Consumer Goods, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
Investing.com -- U.S. stock futures drifted higher early Friday in New York, consolidating overnight gains made after China said it would waive import tariffs on U.S. pork and soybeans....
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Basic Materials, Financials and Technology sectors propelled shares higher. At the close in NYSE, the Dow...
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* Nike rises on Goldman Sachs (NYSE:GS) upgrade* Kroger (NYSE:KR) drops following earnings miss* Sage...
(Fixes typo in first sentence.)* Nike rises on Goldman Sachs (NYSE:GS) upgrade* Kroger (NYSE:KR) drops following earnings miss* Sage sinks as depression drug fails trial* Indexes: Dow up...
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* Nike rises on report of Goldman Sachs (NYSE:GS) upgrade* Kroger (NYSE:KR) drops on quarterly sales,...
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* Nike rises on report of Goldman Sachs (NYSE:GS) upgrade* Kroger (NYSE:KR) drops on quarterly sales,...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Industrials, Technology and Basic Materials sectors propelled shares higher. At the close in NYSE, the...
* Irma further weakens to post-tropical cyclone * Apple dips ahead of expected iPhone launch * Sage Therapeutics slumps after drug fails in study * Indexes up: Dow 0.29 pct, S&P 0.27...
* Irma further weakens to post-tropical cyclone * Apple edges higher ahead of expected iPhone launch * Sage Therapeutics slumps after drug fails in study * Futures up: Dow 56 pts, S&P...
* Futures up: Dow 47 pts, S&P 3.75 pts, Nasdaq 10 pts By Sruthi Shankar Sept 12 (Reuters) - U.S. stock index futures were slightly higher on Tuesday as Irma weakened further into a...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Oil & Gas, Basic Materials and Financials sectors propelled shares higher. At the close in NYSE, the Dow...
* Alcoa (NYSE:AA) up after better-than-expected profit * Oil price bounce boosts energy, materials stocks * Seagate gains on strong preliminary results * Indexes up: Dow 0.47 pct,...
* Alcoa (NYSE:AA) up after better-than-expected profit * Seagate gains on strong preliminary results * Indexes up: Dow 0.63 pct, S&P 0.65 pct, Nasdaq 0.73 pct (Updates to open)...
* Alcoa (NYSE:AA) up after better-than-expected profit * S&P 500 hit record high of 2,143.16 Monday * Futures up: Dow 72 pts, S&P 9.75 pts, Nasdaq 25.25 pts (Adds details,...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.